198 related articles for article (PubMed ID: 7511258)
1. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
Chavin KD; Qin L; Woodward JE; Lin J; Bromberg JS
Transplantation; 1994 Mar; 57(5):736-40. PubMed ID: 7511258
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
[TBL] [Abstract][Full Text] [Related]
3. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.
Qin L; Chavin KD; Lin J; Yagita H; Bromberg JS
J Exp Med; 1994 Jan; 179(1):341-6. PubMed ID: 7903681
[TBL] [Abstract][Full Text] [Related]
5. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
6. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies.
Chavin KD; Lau HT; Bromberg JS
Transplantation; 1992 Aug; 54(2):286-91. PubMed ID: 1353913
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
[TBL] [Abstract][Full Text] [Related]
8. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: evidence for an IL-4 requirement.
Punch JD; Tono T; Qin L; Bishop DK; Bromberg JS
J Immunol; 1998 Aug; 161(3):1156-62. PubMed ID: 9686574
[TBL] [Abstract][Full Text] [Related]
9. Suppression of allograft responses by combining alloantigen-specific i.v. pre-sensitization with suboptimal doses of rapamycin.
Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
Int Immunol; 1994 Jan; 6(1):93-9. PubMed ID: 7511931
[TBL] [Abstract][Full Text] [Related]
10. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat.
Jeske HC; Oberladstätter J; Schneeberger S; Hittmair A; Klima G; Obrist P; Ollinger R; Roberts K; Schubert H; Steurer W; Margreiter R
Transplantation; 2003 Oct; 76(7):1046-52. PubMed ID: 14557751
[TBL] [Abstract][Full Text] [Related]
12. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
13. Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506.
Iwata H; Kitagawa S; Sato S; Kosugi A; Hirose H; Hamaoka T; Shearer GM; Fujiwara H
Transplantation; 1993 Jul; 56(1):173-80. PubMed ID: 7687396
[TBL] [Abstract][Full Text] [Related]
14. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
15. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.
Chavin KD; Qin L; Lin J; Woodward JE; Baliga P; Bromberg JS
Ann Surg; 1993 Oct; 218(4):492-501; discussion 501-3. PubMed ID: 8215640
[TBL] [Abstract][Full Text] [Related]
16. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
Gao L; Woo J; Buelow R
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
[TBL] [Abstract][Full Text] [Related]
18. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
[TBL] [Abstract][Full Text] [Related]
19. Long-term acceptance of major histocompatibility complex-mismatched cardiac allograft induced by a low dose of CTLA4IgM plus FK506.
Yamada A; Murakami M; Ijima K; Yagita H; Okumura K; Komatsu S; Uede T
Microbiol Immunol; 1996; 40(7):513-8. PubMed ID: 8865157
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.
Taylor PA; Lees CJ; Wilson JM; Ehrhardt MJ; Campbell MT; Noelle RJ; Blazar BR
Blood; 2002 Nov; 100(9):3400-7. PubMed ID: 12384443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
